AstraZeneca delivers rare win for treme in liver cancer, bouncing back from flops to beat Bayer’s Nexavar
AstraZeneca delivers rare win for treme in liver cancer, bouncing [...]
AstraZeneca delivers rare win for treme in liver cancer, bouncing [...]
Chinese biopharma powerhouse continues charge into siRNA with Silence R&D [...]
Protein that manipulates gene expression inside the cell nucleus could [...]
Omega, eyeing new uses for genome-tuning tech, taps Stanford to [...]
OnKure sets Diamond in C-suite ahead of Pfizer drug combo [...]
After 15 years helping lead early cancer research at Genentech, [...]
Novel protein degrader against ‘undruggable’ cancer target inhibits tumors in [...]
Aum bags $27M to hit cancer targets pursued by Bayer, [...]
Apnimed sees positives in midstage data for its attempt at [...]
J&J science chief Stoffels to retire after decade at the [...]